News on UCB S.A from BioPortfolio.com http://www.BioPortfolio.com Consolidated UCB S.A news from BioPortfolio.com Wed, 10 Feb 2010 07:19:22 GMT en Approach patents body first: HC to pharma firmshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032922&HITNO=0&MSIZE=171&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=UCB%20S.A&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032922&THISHREF=http://c.moreover.com/click/here.pl%3fz2534883890%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032922&HITNO=0&MSIZE=171&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=UCB%20S.A&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032922&THISHREF=http://c.moreover.com/click/here.pl%3fz2534883890%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBusiness Standard India: Digital Pharma: UCBs online epilepsy communityhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032069&HITNO=1&MSIZE=171&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=UCB%20S.A&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032069&THISHREF=http://c.moreover.com/click/here.pl%3fz2534493654%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032069&HITNO=1&MSIZE=171&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=UCB%20S.A&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032069&THISHREF=http://c.moreover.com/click/here.pl%3fz2534493654%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmafocus: NICE warns industry on cost-effectivenesshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036369&HITNO=2&MSIZE=171&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=UCB%20S.A&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036369&THISHREF=http://c.moreover.com/click/here.pl%3fz2536587222%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036369&HITNO=2&MSIZE=171&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=UCB%20S.A&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036369&THISHREF=http://c.moreover.com/click/here.pl%3fz2536587222%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmafocus: BRIEF: Court throws out pharma co's patent claimhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034379&HITNO=3&MSIZE=171&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=UCB%20S.A&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034379&THISHREF=http://c.moreover.com/click/here.pl%3fz2535752598%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034379&HITNO=3&MSIZE=171&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=UCB%20S.A&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034379&THISHREF=http://c.moreover.com/click/here.pl%3fz2535752598%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: Court throws out pharma cos patent claimhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031134&HITNO=4&MSIZE=171&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=UCB%20S.A&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031134&THISHREF=http://c.moreover.com/click/here.pl%3fz2534020263%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031134&HITNO=4&MSIZE=171&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=UCB%20S.A&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031134&THISHREF=http://c.moreover.com/click/here.pl%3fz2534020263%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comLivemint.com: Exane BNP Paribas ups UCB target to EUR 40http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029599&HITNO=5&MSIZE=171&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=UCB%20S.A&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029599&THISHREF=http://c.moreover.com/click/here.pl%3fz2533203007%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029599&HITNO=5&MSIZE=171&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=UCB%20S.A&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029599&THISHREF=http://c.moreover.com/click/here.pl%3fz2533203007%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comADP News: Pharma Job Cuts: Is There A Strategy behind The Trend?http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027844&HITNO=6&MSIZE=171&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=UCB%20S.A&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027844&THISHREF=http://c.moreover.com/click/here.pl%3fz2532418262%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027844&HITNO=6&MSIZE=171&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=UCB%20S.A&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027844&THISHREF=http://c.moreover.com/click/here.pl%3fz2532418262%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEyeForPharma.com: Miguel Forte joins TxCellhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4021216&HITNO=7&MSIZE=171&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=UCB%20S.A&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4021216&THISHREF=http://c.moreover.com/click/here.pl%3fz2527155438%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4021216&HITNO=7&MSIZE=171&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=UCB%20S.A&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4021216&THISHREF=http://c.moreover.com/click/here.pl%3fz2527155438%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmafocus: Digital Pharma: UCBs online epilepsy communityhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4017480&HITNO=8&MSIZE=171&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=UCB%20S.A&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4017480&THISHREF=http://c.moreover.com/click/here.pl%3fz2525163565%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4017480&HITNO=8&MSIZE=171&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=UCB%20S.A&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4017480&THISHREF=http://c.moreover.com/click/here.pl%3fz2525163565%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmafocus: Taro Receives FDA Approval for Levetiracetam Tabletshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4002434&HITNO=9&MSIZE=171&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=UCB%20S.A&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4002434&THISHREF=http://c.moreover.com/click/here.pl%3fz2518972836%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4002434&HITNO=9&MSIZE=171&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=UCB%20S.A&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4002434&THISHREF=http://c.moreover.com/click/here.pl%3fz2518972836%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Taro gets FDA approval for levetiracetam tabletshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4002364&HITNO=10&MSIZE=171&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=UCB%20S.A&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4002364&THISHREF=http://c.moreover.com/click/here.pl%3fz2518906626%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4002364&HITNO=10&MSIZE=171&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=UCB%20S.A&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4002364&THISHREF=http://c.moreover.com/click/here.pl%3fz2518906626%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Ambassadors of Purple selected to help promote Purple Day for Epilepsyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4004439&HITNO=11&MSIZE=171&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=UCB%20S.A&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4004439&THISHREF=http://c.moreover.com/click/here.pl%3fz2519964084%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4004439&HITNO=11&MSIZE=171&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=UCB%20S.A&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4004439&THISHREF=http://c.moreover.com/click/here.pl%3fz2519964084%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: XOMA Plunges on $21M Offering; Is Diabetes Drug Partner Near?http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4002258&HITNO=12&MSIZE=171&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=UCB%20S.A&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4002258&THISHREF=http://c.moreover.com/click/here.pl%3fz2518824855%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4002258&HITNO=12&MSIZE=171&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=UCB%20S.A&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4002258&THISHREF=http://c.moreover.com/click/here.pl%3fz2518824855%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Taro Receives FDA Approval for Levetiracetam Tabletshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4000121&HITNO=13&MSIZE=171&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=UCB%20S.A&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4000121&THISHREF=http://c.moreover.com/click/here.pl%3fz2517849376%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4000121&HITNO=13&MSIZE=171&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=UCB%20S.A&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4000121&THISHREF=http://c.moreover.com/click/here.pl%3fz2517849376%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: 2/2/10 - Taro Receives FDA Approval for Levetiracetam Tabletshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4000085&HITNO=14&MSIZE=171&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=UCB%20S.A&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4000085&THISHREF=http://c.moreover.com/click/here.pl%3fz2517832712%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4000085&HITNO=14&MSIZE=171&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=UCB%20S.A&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4000085&THISHREF=http://c.moreover.com/click/here.pl%3fz2517832712%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: